PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML

Clinical trial NCT00303290 · COMPLETED

Trial details

NCT number: NCT00303290
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2000-01-01
Primary completion: 2014-11-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.